RxSight publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/05/2025 | RXST | RxSight | FY | 2025 | — | — | — | $125.00M | $130.00M | $125.80M | |
08/07/2025 | RXST | RxSight | FY | 2025 | — | — | — | $120.00M | $130.00M | $126.47M | |
07/08/2025 | RXST | RxSight | Q2 | 2025 | — | — | — | $33.60M | $33.60M | $39.78M | |
07/08/2025 | RXST | RxSight | FY | 2025 | — | — | — | $120.00M | $130.00M | $167.56M | |
05/07/2025 | RXST | RxSight | FY | 2025 | — | — | — | $160.00M | $175.00M | $170.34M | |
04/02/2025 | RXST | RxSight | FY | 2025 | — | — | — | $160.00M | $175.00M | $190.17M | |
04/02/2025 | RXST | RxSight | Q1 | 2025 | — | — | — | $37.90M | $37.90M | $39.80M | |
02/25/2025 | RXST | RxSight | FY | 2025 | — | — | — | $185.00M | $197.00M | $189.33M | |
01/12/2025 | RXST | RxSight | FY | 2024 | — | — | — | $139.90M | $139.90M | $139.98M | |
01/12/2025 | RXST | RxSight | FY | 2025 | — | — | — | $185.00M | $197.00M | $187.92M | |
01/12/2025 | RXST | RxSight | Q4 | 2024 | — | — | — | $40.20M | $40.20M | $40.27M | |
11/07/2024 | RXST | RxSight | FY | 2024 | — | — | — | $140.00M | $140.00M | $139.64M | |
08/05/2024 | RXST | RxSight | FY | 2024 | — | — | — | $139.00M | $140.00M | $135.07M | |
05/06/2024 | RXST | RxSight | FY | 2024 | — | — | — | $132.00M | $137.00M | $131.55M | |
02/28/2024 | RXST | RxSight | FY | 2024 | — | — | — | $128.00M | $135.00M | $128.56M | |
01/08/2024 | RXST | RxSight | FY | 2024 | — | — | — | $128.00M | $135.00M | $121.46M | |
01/08/2024 | RXST | RxSight | FY | 2023 | — | — | — | $89.10M | $89.10M | $86.34M | |
01/08/2024 | RXST | RxSight | Q4 | 2023 | — | — | — | $28.60M | $28.60M | $25.76M | |
11/09/2023 | RXST | RxSight | FY | 2023 | — | — | — | $85.00M | $87.00M | $83.93M | |
08/07/2023 | RXST | RxSight | FY | 2023 | — | — | — | $81.00M | $86.00M | $81.88M | |
05/09/2023 | RXST | RxSight | FY | 2023 | — | — | — | $79.00M | $84.00M | $80.60M | |
03/06/2023 | RXST | RxSight | FY | 2023 | — | — | — | $78.00M | $83.00M | $76.70M | |
01/08/2023 | RXST | RxSight | FY | 2022 | — | — | — | $49.00M | $49.00M | $47.57M | |
01/08/2023 | RXST | RxSight | Q4 | 2022 | — | — | — | $16.10M | $16.10M | $14.63M | |
11/07/2022 | RXST | RxSight | FY | 2022 | — | — | — | $47.00M | $48.00M | $45.24M | |
08/08/2022 | RXST | RxSight | FY | 2022 | — | — | — | $44.00M | $46.00M | $43.97M | |
05/05/2022 | RXST | RxSight | FY | 2022 | — | — | — | $41.50M | $45.50M | $42.26M | |
03/08/2022 | RXST | RxSight | FY | 2022 | — | — | — | $40.00M | $44.00M | $38.47M | |
01/09/2022 | RXST | RxSight | Q4 | 2021 | — | — | — | $8.40M | $8.40M | $7.07M | |
01/09/2022 | RXST | RxSight | FY | 2021 | — | — | — | $22.60M | $22.60M | $21.23M | |
11/10/2021 | RXST | RxSight | FY | 2021 | — | — | — | $21.00M | $21.40M | $20.87M |
Il n'y a eu aucune orientation spécifique sur les ventes ou les bénéfices rapportée pour RxSight ces derniers mois.
Parcourir guidance et prévisions sur toutes les actions.